Miljkovic Milos — SEC Form 4 filings
SEC reporting owner CIK 2000282. 6 Form 4 filings on record with FilingPulse; latest filed 2026-01-08.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-04-10 to 2026-01-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 60,453 shares, $963,441 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 35,000 shares @ $16.13 ($564,644) in Cartesian Therapeutics, Inc., filed 2024-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Chief Medical Officer | 6 | — | 5 legs · 60,453 sh · $963,441 | 10 |
Form 4 filings — Miljkovic Milos
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-08 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Sale (S): 3,573 @ $6.82 | EDGAR |
| 2026-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 27,000 @ $0 · Grant/award (A): 77,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Sale (S): 932 @ $16.72 · Sale (S): 948 @ $16.83 | EDGAR |
| 2025-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 19,000 @ $0 · Grant/award (A): 56,000 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 35,000 @ $3.23 · Sale (S): 35,000 @ $16.13 · Option exercise (M): 20,000 @ $3.23 · Sale (S): 20,000 @ $17.14 · Option exercise (M): 35,000 (derivative) · Option exercise (M): 20,000 (derivative) | EDGAR |
| 2024-04-10 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 2,565.87 (derivative) · Option exercise (M): 85,528 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2000282 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →